A series of novel V-shaped naphthalimide derivatives are reported herein, designed through a strategy to achieve aggregation induced emission (AIE), giving rise to unexpected self-assembly properties. This includes an aggregation induced emission enhancement (AIEE) active small organic molecule viz. naphthalimide derivative functionalized with 8-hydroxyquinoline (α-NQ), that spontaneously forms highly fluorescent “nanoribbon” like structures with <100 nm diameter and hundreds of micron length in aqueous media irrespective of concentration and surface at room temperature. The classical head-to-tail π–π stacking, as revealed by the single crystal X-ray study, was found to be the main driving force for the J-type aggregation with unique self-aggregating behavior. A comparative mechanistic study confirms that the N-atom in the hydroxyquinoline moiety is responsible for directing the entire molecular behavior in solution as well as in its aggregated state. These α-NQ nanoribbons formed in aqueous media were found to be highly sensitive and selective towards the multi-functional nonheme protein ferritin (Ksv = 0.83 × 107 M−1) with a limit of detection 67.25 × 10−11 M (0.33 ng μL−1) under physiological conditions, which serves as a well-known inflammatory marker for various diseases. The fluorescent nanoribbons were also found to modify the α-helix content of ferritin, thereby inducing conformational changes in their secondary structure as confirmed through circular dichroism (CD) spectroscopy techniques. Collectively, these findings improve the fundamental understanding of the self-assembly of AIEE active molecules along with the photophysical properties of core substituted naphthalimide derivatives that report the highest sensitivity towards ferritin in the presence of a bright AIEEgen under physiological conditions.
The accumulation of fluorescent hydroxyquinoline-affixed polyfluorene (PF-HQ) nanoparticles and their utility for multi-color bio-imaging and drug delivery for cancer treatment are reported. The formation of nanoparticles (PF-HQ) containing hydrophobic pockets via three-dimensional growth of a polymeric backbone in a higher water fraction (THF : H2O = 1 : 9) was observed. The nanoparticles showed incredible dual-state optical and fluorescence properties, which were further explored in multi-color cell imaging in both cancer and normal cells. The cell viability assay in various normal cells confirmed the biocompatible nature of PF-HQ, which was further supported by an ex vivo (chick chorioallantoic membrane assay) model. This encouraged us to fabricate PF-HQ-based new drug delivery systems (DDS: PF-HQ–DOX) upon conjugation with the FDA-approved anti-cancer drug doxorubicin (DOX) by filling the hydrophobic pockets of the polymer nanoparticles. The enhanced anti-cancer activity of the DDS (PF-HQ–DOX) compared with that of free DOX was observed in mouse melanoma cancer cells (B16F10) and a subcutaneous mouse (C57BL6/J) melanoma tumor model upon administration of PF-HQ–DOX. Ex vivo biodistribution studies using a fluorescence quantification method demonstrated the enhanced accumulation of DOX in tumor tissues in the PF-HQ–DOX-treated group compared to that of the free drug, signifying the drug delivery efficacy of the delivery system by a passive targeting manner. Based on the above biological data (in vitro and in the pre-clinical model), these robust and versatile fluorescent hydroxyquinoline-affixed polyfluorene (PF-HQ) nanoparticles could be effectively utilized for multifunctional biomedical applications (as they are biocompatible and can be used for bio-imaging and as a drug delivery vehicle).
A novel PDI-HIS probe detects Cu 2+ to form aggregated nonfluorescent complex. Addition of 0.58 ppm ATP to this complex causes its rapid disaggregation thereby recovering the fluorescence by ∼99% in vitro and in A549 living cells.